RecruitingNot ApplicableNCT06494722

Expansion of the T1DES Pilot to a Public Hospital

Evaluating the Feasibility of Type 1 Diabetes Education and Support (T1DES) Intervention to Improve Diabetes Distress Among Black Young Adults


Sponsor

Kaiser Permanente

Enrollment

40 participants

Start Date

Mar 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Diabetes distress has been identified as one of the largest contributors to the racial disparity in glycemic control that disproportionately burdens Black patients ages 18-30 years with type 1 diabetes (T1D). In order to combat this issue, this study assesses the feasibility of the culturally tailored intervention T1DES and evaluates the effect of the T1DES intervention on diabetes outcomes in a pilot randomized clinical trial among Black young adults with T1D.


Eligibility

Min Age: 18 YearsMax Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This trial is expanding a diabetes support program (T1DES) to a public hospital setting to help young Black adults with type 1 diabetes better manage their blood sugar levels. **You may be eligible if...** - You are a patient at Grady Health System - You are between 18 and 30 years old - You have been diagnosed with type 1 diabetes - Your most recent HbA1c is above 7.5% (indicating blood sugar is not well controlled) - You self-identify as Black or African American - You have a cell phone that can send and receive text messages - You can read English and provide informed consent **You may NOT be eligible if...** - You have a developmental delay or cognitive impairment that prevents consent - You have severe visual, hearing, or physical disabilities that would prevent participation - You do not have access to a text-capable phone Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALDiabetes Education

Participants in this arm will receive traditional diabetes education over 5 sessions in the first 3 months of participation and be followed for 6 months.

BEHAVIORALT1DES

Participants in this arm will receive the T1DES behavioral interventions over 5 sessions in the first 3 months of participation and be followed for 6 months.


Locations(1)

Grady Health System

Atlanta, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06494722


Related Trials